Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: First Disclosure from Arm 8 of the Epcore NHL-2 Trial

Joost S.P Vermaat, Joshua Brody, Juraj Ďuraš, Yasmin H. Karimi, Chan Y. Cheah, Justin M. Darrah, Gerardo Musuraca, Franck Morschhauser, Daniela Hoehn, Ali Rana, Yaou Song, Pegah Jafarinasabian, David Belada

Blood (2023) 142 (Supplement 1): 4457.

https://doi.org/10.1182/blood-2023-180935

Published: 2023

Journal Articles

Seven-Day Vein-to-Vein Point-of-Care Manufactured CD19 CAR T Cells (GLPG5101) in Relapsed/Refractory NHL: Results from the Phase 1 Atalanta-1 Trial

Marie José Kersten, Kirsten Saevels, Yves Beguin, Joost S.P Vermaat, Nadia Verbruggen, Maike Spoon, Marte C. Liefaard, Margot Pont, Anna D.D. van Muyden, Maria T. Kuipers, Sébastien Anguille

Blood (2023) 142 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2023-172736

Published: 2023

Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

Blood (2023) 142 (Supplement 1): 3090.

https://doi.org/10.1182/blood-2023-181707

Published: 2023

Journal Articles

Antigen-Independent, Autonomous B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Janneke A. Eken, Marvyn T. Koning, Julieta H. Sepulveda Yanez, Cornelis A.M. van Bergen, Edwin Quinten, Kristyna Kupcova, Ondrej Havranek, Ruben A.L. De Groen, Joost S.P. Vermaat, Daphne de Jong, Philip Kluin, Arjen Cleven, Hassan Jumaa, Hendrik Veelken

Blood (2022) 140 (Supplement 1): 6444–6445.

https://doi.org/10.1182/blood-2022-159420

Published: 2022

Journal Articles

Subcutaneous Epcoritamab in Combination with Rituximab + Lenalidomide (R 2 ) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial

Blood (2022) 140 (Supplement 1): 1471–1473.

https://doi.org/10.1182/blood-2022-158232

Published: 2022

Journal Articles

Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

Nick Veltmaat, Geok Wee Tan, Johanna A.A. Bult, Yujie Zhong, Wouter J. Plattel, Rogier Mous, Pim Mutsaers, Wendy B.C. Stevens, Joost S.P. Vermaat, Martine E.D. Chamuleau, Arjan Diepstra, Anke Van Den Berg, Filipe Montes De Jesus, Marcel Nijland

Blood (2022) 140 (Supplement 1): 9274–9276.

https://doi.org/10.1182/blood-2022-171213

Published: 2022

Journal Articles

Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Peter A. Von Dem Borne, Berit M. Kemps-Mols, Liesbeth C. de Wreede, Adriaan A. van Beek, Tjeerd J.F. Snijders, Danielle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabo, Theo L. Nering Bögel, Mirjam A. Oudshoorn, Constantijn J.M. Halkes, Peter van Balen, Erik W.A.F. Marijt, Jennifer M.L. Tjon, Joost S.P. Vermaat, Hendrik Veelken

Blood (2022) 140 (Supplement 1): 4735–4736.

https://doi.org/10.1182/blood-2022-157012

Published: 2022

Journal Articles

Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia

Peter A. Von Dem Borne, Tjeerd J.F. Snijders, Danielle van Lammeren, Janneke Tijmensen, Erwin V. Planken, Henriette Levenga, Yascha van den Berg, Erik WAF Marijt, Peter van Balen, Jennifer M. Tjon, Joost S.P. Vermaat, Theo L. Nering Bögel, Mirjam A. Oudshoorn, Constantijn J.M. Halkes, Hendrik Veelken

Blood (2022) 140 (Supplement 1): 7742–7743.

https://doi.org/10.1182/blood-2022-157894

Published: 2022

Journal Articles

Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study

Johanna A.A. Bult, Francien Huisman, Yujie Zhong, Nick Veltmaat, Sanne Tonino, Joost S.P. Vermaat, Martine E.D. Chamuleau, Arjan Diepstra, Wouter J. Plattel, Anke Van Den Berg, Mirian Brink, Marcel Nijland

Blood (2022) 140 (Supplement 1): 6514–6516.

https://doi.org/10.1182/blood-2022-166052

Published: 2022

Journal Articles

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Blood (2022) 140 (Supplement 1): 3534–3536.

https://doi.org/10.1182/blood-2022-159036

Published: 2022

Journal Articles

Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 3529–3531.

https://doi.org/10.1182/blood-2022-168668

Published: 2022

Journal Articles

A Propensity Score-Adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for MYC -Rearranged DLBCL Patients

A. Vera de Jonge, Erik D. van Werkhoven, Avinash G. Dinmohamed, Marcel Nijland, Aeilko H. Zwinderman, Patrick M. Bossuyt, Martine S. Veldhuis, Emma G.G.M. Rutten, Rogier Mous, Joost S.P. Vermaat, Yorick Sandberg, Eva de Jongh, Yavuz M. Bilgin, Rinske Boersma, Harry R. Koene, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau

Blood (2022) 140 (Supplement 1): 2059–2060.

https://doi.org/10.1182/blood-2022-163204

Published: 2022

Journal Articles

Autonomous BCR Signaling and Genetic Aberrations in CLL-Phenotype Monoclonal B Lymphocytosis in Siblings of CLL Patients

Julieta H. Sepulveda Yanez, Edwin Quinten, Marvyn T. Koning, Janneke A. Eken, Dietmar Pfeifer, Ruben A.L. De Groen, Diego Alvarez Saravia, Andreas Agathangelidis, Cornelis A.M. van Bergen, Kostas Stamatopoulos, Joost S.P. Vermaat, Katja Zirlik, Marcelo Navarrete, Hassan Jumaa, Hendrik Veelken

Blood (2022) 140 (Supplement 1): 1526–1527.

https://doi.org/10.1182/blood-2022-169429

Published: 2022

Journal Articles

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Blood (2022) 140 (Supplement 1): 369–371.

https://doi.org/10.1182/blood-2022-163244

Published: 2022

Journal Articles

Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

Blood (2022) 140 (Supplement 1): 164–165.

https://doi.org/10.1182/blood-2022-156103

Published: 2022

Journal Articles

Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

Lorraine M. De Haan, Ruben A.L. De Groen, Fleur de Groot, Troy Noordenbos, Tom van Wezel, Ronald van Eijk, Dina Ruano, Arjan Diepstra, Lianne Koens, Aniko Sijs-Szabo, Hendrik Veelken, Arjen Cleven, Patty M. Jansen, Joost S.P. Vermaat

Blood (2022) 140 (Supplement 1): 11916–11918.

https://doi.org/10.1182/blood-2022-163197

Published: 2022

Journal Articles

Low Mutational Burden of Extra Nodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome

Johanna A.A. Bult, Jessica R. Plaça, Erlin A. Haacke, Gwenny M. Verstappen, Frederik K.L. Spijkervet, Frans G.M. Kroese, Wouter J. Plattel, Joost S.P. Vermaat, Hendrika Bootsma, Bert Van der Vegt, Arjan Diepstra, Anke Van Den Berg, Klaas Kok, Marcel Nijland

Blood (2021) 138 (Supplement 1): 1331.

https://doi.org/10.1182/blood-2021-153130

Published: 2021

Journal Articles

First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study

Frederik O. Meeuwes, Mirian Brink, Marjolein W.M. Van Der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G.N.J. Mutsaers, Lara H. Böhmer, F.J. Sherida H. Woei-a-Jin, Otto J. Visser, Rimke Oostvogels, Patty M. Jansen, Karen J. Neelis, Anne P.G. Crijns, Laurien A. Daniëls, Joost S.P. Vermaat, Gerwin A. Huls, Marcel Nijland

Blood (2021) 138 (Supplement 1): 1381.

https://doi.org/10.1182/blood-2021-148038

Published: 2021

NARROW

Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: First Disclosure from Arm 8 of the Epcore NHL-2 Trial

Seven-Day Vein-to-Vein Point-of-Care Manufactured CD19 CAR T Cells (GLPG5101) in Relapsed/Refractory NHL: Results from the Phase 1 Atalanta-1 Trial

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

Antigen-Independent, Autonomous B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Subcutaneous Epcoritamab in Combination with Rituximab + Lenalidomide (R 2 ) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial

Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia

Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

A Propensity Score-Adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for MYC -Rearranged DLBCL Patients

Autonomous BCR Signaling and Genetic Aberrations in CLL-Phenotype Monoclonal B Lymphocytosis in Siblings of CLL Patients

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

Low Mutational Burden of Extra Nodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome

First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only